Global Flu Vaccine Market Outlook 2023

Report ID: 1128511 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Flu Vaccine Market Overview
    1.1 Product Overview and Scope of Flu Vaccine
    1.2 Flu Vaccine Segment by Type
        1.2.1 Global Flu Vaccine Sales Growth Rate Comparison by Type (2021-2027)
        1.2.2 Trivalent Influenza Vaccine
        1.2.3 Quadrivalent Influenza Vaccine
    1.3 Flu Vaccine Segment by Application
        1.3.1 Global Flu Vaccine Sales Comparison by Application: (2021-2027)
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Global Flu Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Flu Vaccine Revenue 2016-2027
        1.4.2 Global Flu Vaccine Sales 2016-2027
        1.4.3 Flu Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Flu Vaccine Market Competition by Manufacturers
    2.1 Global Flu Vaccine Sales Market Share by Manufacturers (2016-2021)
    2.2 Global Flu Vaccine Revenue Market Share by Manufacturers (2016-2021)
    2.3 Global Flu Vaccine Average Price by Manufacturers (2016-2021)
    2.4 Manufacturers Flu Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Flu Vaccine Market Competitive Situation and Trends
        2.5.1 Flu Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Flu Vaccine Players Market Share by Revenue
        2.5.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Flu Vaccine Retrospective Market Scenario by Region
    3.1 Global Flu Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
    3.2 Global Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
    3.3 North America Flu Vaccine Market Facts & Figures by Country
        3.3.1 North America Flu Vaccine Sales by Country
        3.3.2 North America Flu Vaccine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Flu Vaccine Market Facts & Figures by Country
        3.4.1 Europe Flu Vaccine Sales by Country
        3.4.2 Europe Flu Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Flu Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Flu Vaccine Sales by Region
        3.5.2 Asia Pacific Flu Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Flu Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Flu Vaccine Sales by Country
        3.6.2 Latin America Flu Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Flu Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Flu Vaccine Sales by Country
        3.7.2 Middle East and Africa Flu Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Flu Vaccine Historic Market Analysis by Type
    4.1 Global Flu Vaccine Sales Market Share by Type (2016-2021)
    4.2 Global Flu Vaccine Revenue Market Share by Type (2016-2021)
    4.3 Global Flu Vaccine Price by Type (2016-2021)

5 Global Flu Vaccine Historic Market Analysis by Application
    5.1 Global Flu Vaccine Sales Market Share by Application (2016-2021)
    5.2 Global Flu Vaccine Revenue Market Share by Application (2016-2021)
    5.3 Global Flu Vaccine Price by Application (2016-2021)

6 Key Companies Profiled
    6.1 Sanofi Pasteur
        6.1.1 Sanofi Pasteur Corporation Information
        6.1.2 Sanofi Pasteur Description and Business Overview
        6.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.1.4 Sanofi Pasteur Flu Vaccine Product Portfolio
        6.1.5 Sanofi Pasteur Recent Developments/Updates
    6.2 CSL
        6.2.1 CSL Corporation Information
        6.2.2 CSL Description and Business Overview
        6.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.2.4 CSL Flu Vaccine Product Portfolio
        6.2.5 CSL Recent Developments/Updates
    6.3 GSK
        6.3.1 GSK Corporation Information
        6.3.2 GSK Description and Business Overview
        6.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.3.4 GSK Flu Vaccine Product Portfolio
        6.3.5 GSK Recent Developments/Updates
    6.4 Mylan
        6.4.1 Mylan Corporation Information
        6.4.2 Mylan Description and Business Overview
        6.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 Mylan Flu Vaccine Product Portfolio
        6.4.5 Mylan Recent Developments/Updates
    6.5 Hulan Bio
        6.5.1 Hulan Bio Corporation Information
        6.5.2 Hulan Bio Description and Business Overview
        6.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.5.4 Hulan Bio Flu Vaccine Product Portfolio
        6.5.5 Hulan Bio Recent Developments/Updates
    6.6 AstraZeneca
        6.6.1 AstraZeneca Corporation Information
        6.6.2 AstraZeneca Description and Business Overview
        6.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.6.4 AstraZeneca Flu Vaccine Product Portfolio
        6.6.5 AstraZeneca Recent Developments/Updates
    6.7 CCBIO
        6.6.1 CCBIO Corporation Information
        6.6.2 CCBIO Description and Business Overview
        6.6.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
        6.4.4 CCBIO Flu Vaccine Product Portfolio
        6.7.5 CCBIO Recent Developments/Updates

7 Flu Vaccine Manufacturing Cost Analysis
    7.1 Flu Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Flu Vaccine
    7.4 Flu Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Flu Vaccine Distributors List
    8.3 Flu Vaccine Customers

9 Flu Vaccine Market Dynamics
    9.1 Flu Vaccine Industry Trends
    9.2 Flu Vaccine Growth Drivers
    9.3 Flu Vaccine Market Challenges
    9.4 Flu Vaccine Market Restraints

10 Global Market Forecast
    10.1 Flu Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Flu Vaccine by Type (2022-2027)
        10.1.2 Global Forecasted Revenue of Flu Vaccine by Type (2022-2027)
    10.2 Flu Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Flu Vaccine by Application (2022-2027)
        10.2.2 Global Forecasted Revenue of Flu Vaccine by Application (2022-2027)
    10.3 Flu Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Flu Vaccine by Region (2022-2027)
        10.3.2 Global Forecasted Revenue of Flu Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Flu Vaccine Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
    Table 2. Global Flu Vaccine Sales (M Doses) Comparison by Application (2021-2027)
    Table 3. Global Flu Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
    Table 4. Key Manufacturers Flu Vaccine Covered in This Study
    Table 5. Global Flu Vaccine Sales (M Doses) of Key Manufacturers (2016-2021)
    Table 6. Global Flu Vaccine Sales Market Share by Manufacturers (2016-2021)
    Table 7. Global Flu Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
    Table 8. Global Flu Vaccine Revenue Share by Manufacturers (2016-2021)
    Table 9. Global Market Flu Vaccine Average Price (US$/Dose) of Key Manufacturers (2016-2021)
    Table 10. Manufacturers Flu Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Flu Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu Vaccine as of 2020)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Flu Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 16. Global Flu Vaccine Sales Market Share by Region (2016-2021)
    Table 17. Global Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 18. North America Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 19. North America Flu Vaccine Sales Market Share by Country (2016-2021)
    Table 20. North America Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 21. North America Flu Vaccine Revenue Market Share by Country (2016-2021)
    Table 22. Europe Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 23. Europe Flu Vaccine Sales Market Share by Country (2016-2021)
    Table 24. Europe Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 25. Europe Flu Vaccine Revenue Market Share by Country (2016-2021)
    Table 26. Asia Pacific Flu Vaccine Sales by Region (2016-2021) & (M Doses)
    Table 27. Asia Pacific Flu Vaccine Sales Market Share by Region (2016-2021)
    Table 28. Asia Pacific Flu Vaccine Revenue by Region (2016-2021) & (US$ Million)
    Table 29. Asia Pacific Flu Vaccine Revenue Market Share by Region (2016-2021)
    Table 30. Latin America Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 31. Latin America Flu Vaccine Sales Market Share by Country (2016-2021)
    Table 32. Latin America Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 33. Latin America Flu Vaccine Revenue Market Share by Country (2016-2021)
    Table 34. Middle East and Africa Flu Vaccine Sales by Country (2016-2021) & (M Doses)
    Table 35. Middle East and Africa Flu Vaccine Sales Market Share by Country (2016-2021)
    Table 36. Middle East and Africa Flu Vaccine Revenue by Country (2016-2021) & (US$ Million)
    Table 37. Middle East and Africa Flu Vaccine Revenue Market Share by Country (2016-2021)
    Table 38. Global Flu Vaccine Sales (M Doses) by Type (2016-2021)
    Table 39. Global Flu Vaccine Sales Market Share by Type (2016-2021)
    Table 40. Global Flu Vaccine Revenue (Million US$) by Type (2016-2021)
    Table 41. Global Flu Vaccine Revenue Share by Type (2016-2021)
    Table 42. Global Flu Vaccine Price (US$/Dose) by Type (2016-2021)
    Table 43. Global Flu Vaccine Sales (M Doses) by Application (2016-2021)
    Table 44. Global Flu Vaccine Sales Market Share by Application (2016-2021)
    Table 45. Global Flu Vaccine Revenue (Million US$) by Application (2016-2021)
    Table 46. Global Flu Vaccine Revenue Share by Application (2016-2021)
    Table 47. Global Flu Vaccine Price (US$/Dose) by Application (2016-2021)
    Table 48. Sanofi Pasteur Corporation Information
    Table 49. Sanofi Pasteur Description and Business Overview
    Table 50. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 51. Sanofi Pasteur Flu Vaccine Product
    Table 52. Sanofi Pasteur Recent Developments/Updates
    Table 53. CSL Corporation Information
    Table 54. CSL Description and Business Overview
    Table 55. CSL Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 56. CSL Flu Vaccine Product
    Table 57. CSL Recent Developments/Updates
    Table 58. GSK Corporation Information
    Table 59. GSK Description and Business Overview
    Table 60. GSK Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 61. GSK Flu Vaccine Product
    Table 62. GSK Recent Developments/Updates
    Table 63. Mylan Corporation Information
    Table 64. Mylan Description and Business Overview
    Table 65. Mylan Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 66. Mylan Flu Vaccine Product
    Table 67. Mylan Recent Developments/Updates
    Table 68. Hulan Bio Corporation Information
    Table 69. Hulan Bio Description and Business Overview
    Table 70. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 71. Hulan Bio Flu Vaccine Product
    Table 72. Hulan Bio Recent Developments/Updates
    Table 73. AstraZeneca Corporation Information
    Table 74. AstraZeneca Description and Business Overview
    Table 75. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 76. AstraZeneca Flu Vaccine Product
    Table 77. AstraZeneca Recent Developments/Updates
    Table 78. CCBIO Corporation Information
    Table 79. CCBIO Description and Business Overview
    Table 80. CCBIO Flu Vaccine Sales (M Doses), Revenue (Million US$), Price (US$/Dose) and Gross Margin (2016-2021)
    Table 81. CCBIO Flu Vaccine Product
    Table 82. CCBIO Recent Developments/Updates
    Table 83. Production Base and Market Concentration Rate of Raw Material
    Table 84. Key Suppliers of Raw Materials
    Table 85. Flu Vaccine Distributors List
    Table 86. Flu Vaccine Customers List
    Table 87. Flu Vaccine Market Trends
    Table 88. Flu Vaccine Growth Drivers
    Table 89. Flu Vaccine Market Challenges
    Table 90. Flu Vaccine Market Restraints
    Table 91. Global Flu Vaccine Sales Forecast by Type (2022-2027) & (M Doses)
    Table 92. Global Flu Vaccine Sales Market Share Forecast by Type (2022-2027)
    Table 93. Global Flu Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
    Table 94. Global Flu Vaccine Revenue Market Share Forecast by Type (2022-2027)
    Table 95. Global Flu Vaccine Sales Forecast by Application (2022-2027) & (M Doses)
    Table 96. Global Flu Vaccine Sales Market Share Forecast by Application (2022-2027)
    Table 97. Global Flu Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 98. Global Flu Vaccine Revenue Market Share Forecast by Application (2022-2027)
    Table 99. Global Flu Vaccine Sales Forecast by Region (2022-2027) & (M Doses)
    Table 100. Global Flu Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 101. Global Flu Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 102. Global Flu Vaccine Revenue Market Share Forecast by Region (2022-2027)
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Flu Vaccine
    Figure 2. Global Flu Vaccine Market Share by Type in 2020 & 2027
    Figure 3. Trivalent Influenza Vaccine Product Picture
    Figure 4. Quadrivalent Influenza Vaccine Product Picture
    Figure 5. Global Flu Vaccine Market Share by Application in 2020 & 2027
    Figure 6. For Children (6 months to 3 years)
    Figure 7. For Adults and Children over 3 years
    Figure 8. Global Flu Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Flu Vaccine Market Size 2016-2027 (US$ Million)
    Figure 10. Global Flu Vaccine Sales 2016-2027 (M Doses)
    Figure 11. Global Flu Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
    Figure 12. Flu Vaccine Sales Share by Manufacturers in 2020
    Figure 13. Global Flu Vaccine Revenue Share by Manufacturers in 2020
    Figure 14. The Global 5 and 10 Largest Flu Vaccine Players: Market Share by Revenue in 2020
    Figure 15. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
    Figure 16. Global Flu Vaccine Sales Market Share by Region (2016-2021)
    Figure 17. Global Flu Vaccine Sales Market Share by Region in 2020
    Figure 18. Global Flu Vaccine Revenue Market Share by Region (2016-2021)
    Figure 19. Global Flu Vaccine Revenue Market Share by Region in 2020
    Figure 20. U.S. Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 21. Canada Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 22. Germany Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 23. France Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 24. U.K. Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 25. Italy Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 26. Russia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 27. China Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 28. Japan Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 29. South Korea Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 30. India Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 31. Australia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 32. China Taiwan Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 33. Indonesia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 34. Thailand Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 35. Malaysia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 36. Mexico Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 37. Brazil Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 38. Argentina Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 39. Turkey Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 40. Saudi Arabia Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 41. UAE Flu Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 42. Sales Market Share of Flu Vaccine by Type (2016-2021)
    Figure 43. Sales Market Share of Flu Vaccine by Application (2016-2021)
    Figure 44. Sales Market Share of Flu Vaccine by Application in 2020
    Figure 45. Revenue Share of Flu Vaccine by Application (2016-2021)
    Figure 46. Revenue Share of Flu Vaccine by Application in 2020
    Figure 47. Manufacturing Cost Structure of Flu Vaccine
    Figure 48. Manufacturing Process Analysis of Flu Vaccine
    Figure 49. Flu Vaccine Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Frequently Asked Questions
Flu Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Flu Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Flu Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Agriculture Sprayer

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Air Duster

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More